Trial Information
Korean's Practice Patterns for Screening PCA(Prostate Cancer) According to PSA(Prostate-specific Antigen) Level
This is to investigate Korean urologist's practice patterns for screening prostate cancer
according to PSA level.
Inclusion Criteria:
- Male with PSA more than 2.5ng/ml from 1 Jan 2008 to 31 Dec 2008
Exclusion Criteria:
- Age less than 40 at PSA screening
- History of drug use which can affect level of PSA within 6months before PSA screening
- Subject who participate any other clinical trial
Type of Study:
Observational
Study Design:
Time Perspective: Retrospective
Outcome Measure:
Number of subjects with prostate biopsy
Outcome Time Frame:
1year
Safety Issue:
No
Principal Investigator
GSK Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
GlaxoSmithKline
Authority:
Korea: Institutional Review Board
Study ID:
113951
NCT ID:
NCT01371513
Start Date:
May 2010
Completion Date:
June 2011
Related Keywords:
- Neoplasms, Prostate
- Prostate Cancer
- Benign Prostatic Hyperplasia
- Serum prostate specific antigen
- Prostatic Hyperplasia
- Neoplasms
- Hyperplasia
- Prostatic Neoplasms